Back to Trades
Androski Lindsay
President and CEODirectorCIK 0001936604
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Androski Lindsay, President and CEO, Director, has filed 1 SEC report (2026), all concentrated in Arbutus Biopharma Corp (ABUS), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Feb 2 | ABUS Arbutus Biopharma Corp | Androski Lindsay | President and CEO, Director | Grant | $0 |
1 filing